HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Feline lymphomas: immunological and cytochemical characterization.

Abstract
The immunological and cytochemical phenotypes of five primary feline lymphomas and six feline lymphoma lines are reported. Thymic lymphomas induced by the Rickard strain of FeLV (FeLV-R) are of prothymocyte or (immature) cortical thymocyte origin, as these express terminal deoxynucleotidyl transferase, the guinea pig erythrocyte rosette receptor, Ia antigens, partial cortisone sensitivity, and nonspecific esterase. Lymphomas associated with other strains of FeLV form rosettes with guinea pig erythrocytes, frequently have Ia antigens and cytoplasmic nonspecific esterase, and probably originate from helper T-cells, monocyte/macrophages, or null cells. These data belie previous conclusions that FeLV leukemogenesis is restricted to mature T-cells; rather, the considerable heterogeneity in the surface and cytochemical phenotype of feline lymphomas probably reflects transformation of multipotent lymphoid or monocytoid precursors in the bone marrow by FeLV.
AuthorsJ L Rojko, G J Kociba, J L Abkowitz, K L Hamilton, W D Hardy Jr, J N Ihle, S J O'Brien
JournalCancer research (Cancer Res) Vol. 49 Issue 2 Pg. 345-51 (Jan 15 1989) ISSN: 0008-5472 [Print] United States
PMID2535958 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Interleukin-2
Topics
  • Animals
  • Bone Marrow (microbiology)
  • Bone Marrow Cells
  • Cat Diseases (immunology, pathology)
  • Cats
  • Cell Line
  • Guinea Pigs
  • Immunohistochemistry
  • Interleukin-2 (biosynthesis)
  • Leukemia Virus, Feline
  • Lymphoma (veterinary)
  • Rosette Formation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: